• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Mesoblast Limited - American Depositary Shares (NQ:MESO)

    14.73 -0.05 (-0.34%)
    Streaming Delayed Price Updated: 11:00 AM EDT, Mar 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Mesoblast Limited - American Depositary Shares

    News headline image
    The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
    AVAI, FBLG, FATE, MESO, and LGVN as Regenerative Medicine Moves From Lab to GMP Manufacturing Facilities 
    From USA News Group
    Via GlobeNewswire
    Mesoblast Ltd. (NASDAQ: MESO) Near the Top of Equities by Percentage Gain on 4/1
    Via Investor Brand Network
    Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK
    Via AB Newswire
    Topics Initial Public Offering
    Mesoblast Ltd. (NASDAQ: MESO) is One of Tuesday Morning’s Most Active Stocks
    Via Investor Brand Network
    A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
    Biotechnology companies have broken many medical barriers in the past 40 years, harnessing the technological revolution to bring innovative solutions to medical problems. 
    Via TheNewswire.com
    R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development
    Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia... 
    Via FinancialNewsMedia
    Alzheimer’s Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases
    Palm Beach, FL – January 5, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an... 
    Via FinancialNewsMedia
    Topics Death
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.